CRP and diffuse large B-cell lymphoma: CRP can be a possible prognostic marker for survival in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma, while generally, notable increases have also been reported in some other non-Hodgkin’s and Hodgkin’s lymphomas as well [790,791,792,793,794,795,796].